Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties

Yana Vanlaer, Ester Van de Cauter, Nina Embo, Katrien Benhalima

Open source

DOI
10.1186/s12916-026-05182-3
Published
2026-08-22
Container
BMC Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12916-026-05182-3,
  title = {Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties},
  author = {Yana Vanlaer and Ester Van de Cauter and Nina Embo and Katrien Benhalima},
  year = {2026},
  journal = {BMC Medicine},
  doi = {10.1186/s12916-026-05182-3},
  url = {https://doi.org/10.1186/s12916-026-05182-3}
}

RIS

TY  - JOUR
TI  - Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties
AU  - Yana Vanlaer
AU  - Ester Van de Cauter
AU  - Nina Embo
AU  - Katrien Benhalima
PY  - 2026
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05182-3
UR  - https://doi.org/10.1186/s12916-026-05182-3
ER  - 

APA

Vanlaer, Y., Cauter, E. V. D., Embo, N., & Benhalima, K. (2026). Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties. BMC Medicine. https://doi.org/10.1186/s12916-026-05182-3

Source records